Solvonis Therapeutics plc Stock
Stocks
SVNS
GB00BMD1Z199
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
11:35:10 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.1150 GBX | 0.00% |
|
-6.12% | -62.90% |
| 09-03 | EARNINGS AND TRADING: Zinc Media wins USD6 million film commission | AN |
| 08-25 | Solvonis Therapeutics placing raises GBP1.3 million | AN |
| Market Cap | 7.83M 10.6M 9.12M 8.58M 14.61M 1.01B 14.68M 102M 39.32M 514M 39.82M 38.95M 1.64B | P/E 2026 * |
-2.35x | P/E 2027 * | -2.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.95M 8.07M 6.94M 6.53M 11.11M 765M 11.17M 77.31M 29.91M 391M 30.29M 29.63M 1.24B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
67.69% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SVNS | Delayed | |
OTC Markets
| SLVNF | Delayed | |
|
Deutsche Boerse AG
| J4I | Delayed | |
|
Börse Stuttgart
| J4I | Delayed | |
|
Boerse Muenchen
| J4I | Real-time |
| 1 week | -6.12% | ||
| Current month | -8.00% | ||
| 1 month | -23.33% | ||
| 3 months | -48.66% | ||
| 6 months | -48.89% | ||
| Current year | -62.90% |
| 1 week | 0.11 |  | 0.13 |
| 1 month | 0.11 | | 0.16 |
| Current year | 0.11 | | 0.33 |
| 1 year | 0.11 | | 0.4 |
| 3 years | 0.1 | | 2.6 |
| 5 years | 0.1 | | 22.46 |
| 10 years | 0.1 | | 22.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
CEO | Chief Executive Officer | 50 | 2024-05-01 |
Ryan Neates
DFI | Director of Finance/CFO | 34 | - |
David Nutt
CTO | Chief Tech/Sci/R&D Officer | - | 2025-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
BRD | Director/Board Member | 50 | 2024-05-01 |
Nicholas Nelson
CHM | Chairman | 61 | 2024-03-14 |
Dennis Purcell
CHM | Chairman | 71 | 2024-09-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/10/24 | Free | Director | 10,500,000 | 8.4159% | ||
| 7/10/24 | Free | Responsable ventes & marketing | 8,694,000 | 6.9684% | ||
| 7/10/24 | Free | Director | 10,500,000 | 8.4159% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.12% | -55.77% | -95.40% | 10.6M | |
| -0.82% | -3.77% | -2.49% | +14.92% | 48.41B | |
| -1.29% | -1.22% | +404.92% | +545.45% | 45.01B | |
| -3.20% | +0.33% | +38.11% | +21.39% | 44.07B | |
| -1.89% | -2.00% | +1.45% | +82.46% | 40.73B | |
| -1.72% | -2.61% | +13.09% | +42.33% | 33.21B | |
| -0.17% | +3.78% | - | - | 17.77B | |
| -0.07% | +1.32% | +20.08% | +117.95% | 16.5B | |
| -0.56% | -0.50% | +11.39% | +31.41% | 14.45B | |
| -2.68% | -0.56% | +73.31% | +40.56% | 13.77B | |
| Average | -1.24% | -0.73% | +56.01% | +89.01% | 27.39B | |
| Weighted average by Cap. | -1.54% | -0.74% | +85.04% | +132.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.57M -4.84M -4.16M -3.91M -6.66M -458M -6.7M -46.35M -17.93M -234M -18.16M -17.76M -746M | -4.01M -5.43M -4.67M -4.39M -7.48M -515M -7.52M -52.06M -20.14M -263M -20.4M -19.95M -838M |
| Net Debt | -1.87M -2.54M -2.18M -2.05M -3.49M -240M -3.51M -24.31M -9.41M -123M -9.53M -9.32M -391M | -6.92M -9.37M -8.06M -7.58M -12.91M -889M -12.98M -89.82M -34.75M -454M -35.19M -34.42M -1.45B |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | GBX 0.1150 | 0.00% | 11,381,073 |
| 26-09-07 | GBX 0.1150 | 0.00% | 1,994,583 |
| 26-09-04 | GBX 0.1150 | -4.17% | 18,844,715 |
| 26-09-03 | GBX 0.1200 | +2.13% | 32,152,848 |
| 26-09-02 | GBX 0.1175 | -4.08% | 9,512,096 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001150GBP
Average target price
0.0170GBP
Spread / Average Target
+1,378.26%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SVNS Stock
Select your edition
All financial news and data tailored to specific country editions
